S-1/A Filing

22ND CENTURY GROUP, INC. CIK: 1347858

Filing Information

Form Type	S-1/A
Accession Number	`0001144204-13-017952`
Period End Date	20121231
Filing Date	20130327
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	xxii-20130327.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 77 Income Statement 38 Cash Flow Statement 102 Stockholders Equity 24

Balance Sheet 77 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$252.25K	USD	Point-in-time
Cash	`Cash`	$310.00	USD	Point-in-time
Cash	`Cash`	$188.00	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$15.49K	USD	Point-in-time
Due from related party	`DueFromRelatedPartiesCurrent`	$36.97K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Due from officers	`DueFromOfficersOrStockholdersCurrent`	$7.71K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Due from officers	`DueFromOfficersOrStockholdersCurrent`	$3.58K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory	`InventoryNet`	$1.23M	USD	Point-in-time
Inventory	`InventoryNet`	$678.12K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$10.04K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	34.29M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.68K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$971.25K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	34.29M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.28M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.35M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.39M	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$6.03K	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$7.86K	USD	Point-in-time
Deferred debt issuance costs, net	`DeferredFinanceCostsNoncurrentNet`	$22.41K	USD	Point-in-time
Deferred debt issuance costs, net	`DeferredFinanceCostsNoncurrentNet`	$4.23K	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.36M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Total assets	`Assets`	$2.64M	USD	Point-in-time
Total assets	`Assets`	$2.39M	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.41M	USD	Point-in-time
Accrued interest payable to related parties	`InterestPayableRelatedPartiesCurrent`	$6.04K	USD	Point-in-time
Accrued interest payable to related parties	`InterestPayableRelatedPartiesCurrent`	$3.57K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$561.04K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$503.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$617.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$425.00K	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleNotesPayableCurrent`	$1.89M	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleNotesPayableCurrent`	$641.89K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.87M	USD	Point-in-time
Long term portion of notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Long term portion of notes payable	`LongTermNotesPayable`	$177.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$550.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$4.17M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$3.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.78M	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 11)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares 10,000,000 authorized: $.00001 par value: 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares 10,000,000 authorized: $.00001 par value: 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares 300,000,000 authorized: .00001 par value: 34,286,979 (27,209,646 at December 31, 2011) issued and outstanding	`CommonStockValue`	$273.00	USD	Point-in-time
Common shares 300,000,000 authorized: .00001 par value: 34,286,979 (27,209,646 at December 31, 2011) issued and outstanding	`CommonStockValue`	$344.00	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$7.65M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$5.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.04M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-13.78M	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	-	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$5.98K	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-6.13M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.39M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.64M	USD	Point-in-time

Income Statement 38 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$18.77K	USD	Annual
Revenue	`SalesRevenueNet`	$788.60K	USD	Annual
Other income - therapeutic grant	`RevenueFromGrants`	-	USD	Annual
Other income - therapeutic grant	`RevenueFromGrants`	$223.54K	USD	Annual
Total revenue	`Revenues`	$1.01M	USD	Annual
Total revenue	`Revenues`	$18.77K	USD	Annual
Costs of goods sold	`CostOfGoodsSold`	$67.97K	USD	Annual
Costs of goods sold	`CostOfGoodsSold`	$418.17K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$729.23K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.10M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$2.21M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$1.79M	USD	Annual
Sales and marketing costs	`SellingAndMarketingExpense`	$61.88K	USD	Annual
Sales and marketing costs	`SellingAndMarketingExpense`	$286.03K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$198.41K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$179.95K	USD	Annual
Total operating expenses	`CostsAndExpenses`	$4.77M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$3.26M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.24M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-3.76M	USD	Annual
Warrant liability change - net	`DerivativeGainsLossesNet`	$2.51M	USD	Annual
Warrant liability change - net	`DerivativeGainsLossesNet`	$-2.00M	USD	Annual
Related parties	`InterestExpenseRelatedParty`	$45.93K	USD	Annual
Related parties	`InterestExpenseRelatedParty`	$272.76K	USD	Annual
Other	`InterestExpenseOther`	$1.22M	USD	Annual
Other	`InterestExpenseOther`	$58.07K	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$2.41M	USD	Annual
Total other income (expense)	`NonoperatingIncomeExpense`	$-3.49M	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-6.74M	USD	Annual
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.12K	USD	Annual
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.46K	USD	Annual
Net loss attributed to common shareholders	`NetIncomeLoss`	$-6.74M	USD	Annual
Net loss attributed to common shareholders	`NetIncomeLoss`	$-1.35M	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	Annual
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.22	USD	Annual
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	30.42M	shares	Annual
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	26.39M	shares	Annual

Cash Flow Statement 102 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-6.74M	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$198.41K	USD	Annual
Amortization and depreciation	`DepreciationAndAmortization`	$179.95K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$18.17K	USD	Annual
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$1.09K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$34.09K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.37M	USD	Annual
Interest due to debt conversion	`NonCashInterestOnConvertibleDebt`	$31.35K	USD	Annual
Interest due to debt conversion	`NonCashInterestOnConvertibleDebt`	-	USD	Annual
Loss (gain) warrant liability - derivative	`DerivativeGainsLossesNet`	$2.51M	USD	Annual
Loss (gain) warrant liability - derivative	`DerivativeGainsLossesNet`	$-2.00M	USD	Annual
Equity based employee compensation expense	`ShareBasedCompensation`	$376.44K	USD	Annual
Equity based employee compensation expense	`ShareBasedCompensation`	$807.67K	USD	Annual
Convertible note issued for outside services	`IssuanceOfConvertibleNotesForServicesOrClaims`	-	USD	Annual
Convertible note issued for outside services	`IssuanceOfConvertibleNotesForServicesOrClaims`	$60.00K	USD	Annual
Equity based payments for outside services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$416.50K	USD	Annual
Equity based payments for outside services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	Annual
Stock issued for directors fees	`StockIssuedDuringPeriodValueOther`	$-30.00K	USD	Annual
Stock issued for directors fees	`StockIssuedDuringPeriodValueOther`	-	USD	Annual
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$-223.54K	USD	Annual
Grant receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$552.40K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$369.46K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-7.63K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-194.04K	USD	Annual
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-1.53K	USD	Annual
Deposits	`IncreaseDecreaseInDepositOtherAssets`	-	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-222.66K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$705.41K	USD	Annual
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToRelatedParties`	$-162.77K	USD	Annual
Accrued interest payable to shareholders	`IncreaseDecreaseInDueToRelatedParties`	$-2.47K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-58.04K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$317.86K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-223.54K	USD	Annual
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.76M	USD	Annual
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.45M	USD	Annual
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$598.19K	USD	Annual
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$162.77K	USD	Annual
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	-	USD	Annual
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	$9.11K	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-607.30K	USD	Annual
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-162.77K	USD	Annual
Proceeds from issuance of notes	`ProceedsFromNotesPayable`	$56.00K	USD	Annual
Proceeds from issuance of notes	`ProceedsFromNotesPayable`	$215.00K	USD	Annual
Payments on borrowings - notes payable	`RepaymentsOfNotesPayable`	$443.28K	USD	Annual
Payments on borrowings - notes payable	`RepaymentsOfNotesPayable`	$41.00K	USD	Annual
Net proceeds from private placement	`ProceedsFromIssuanceOrSaleOfEquity`	$681.00K	USD	Point-in-time
Net proceeds from private placement	`ProceedsFromIssuanceOrSaleOfEquity`	$786.50K	USD	Point-in-time
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$1.30M	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$210.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$23.50K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Net payments to related party	`RepaymentsOfRelatedPartyDebt`	$21.48K	USD	Annual
Net payments to related party	`RepaymentsOfRelatedPartyDebt`	$22.43K	USD	Annual
Net advances from (payments to) officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$-10.91K	USD	Annual
Net advances from (payments to) officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$4.14K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.31M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.68M	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-252.06K	USD	Annual
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$251.94K	USD	Annual
Cash - beginning of period	`Cash`	$252.25K	USD	Point-in-time
Cash - beginning of period	`Cash`	$310.00	USD	Point-in-time
Cash - beginning of period	`Cash`	$188.00	USD	Point-in-time
Cash - end of period	`Cash`	$252.25K	USD	Point-in-time
Cash - end of period	`Cash`	$310.00	USD	Point-in-time
Cash - end of period	`Cash`	$188.00	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$15.32K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$196.54K	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Common stock issued as payment of accounts payable	`IssuanceOfCommonStockInExchangeForAccountPayable`	$-359.75K	USD	Annual
Common stock issued as payment of accounts payable	`IssuanceOfCommonStockInExchangeForAccountPayable`	-	USD	Annual
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	$500.00K	USD	Annual
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	-	USD	Annual
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	$526.13K	USD	Annual
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	-	USD	Annual
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	-	USD	Annual
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	$587.00K	USD	Annual
Total supplemental accounts payable	`SupplementalAccountsPayable`	$1.61M	USD	Annual
Total supplemental accounts payable	`SupplementalAccountsPayable`	$359.75K	USD	Annual
Non controlling interest acquired for common stock	`AcquiredNoncontrollingInterest`	$4.53K	USD	Annual
Non controlling interest acquired for common stock	`AcquiredNoncontrollingInterest`	-	USD	Annual
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	$587.13K	USD	Annual
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	-	USD	Annual
Notes payable converted to common shares	`ConversionOfConvertibleNotesToCommonStock`	-	USD	Annual
Notes payable converted to common shares	`ConversionOfConvertibleNotesToCommonStock`	$120.75K	USD	Annual
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfNotesPayableToCommonStockBadExtended`	-	USD	Annual
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfNotesPayableToCommonStockBadExtended`	$614.07K	USD	Annual
Original issue discount on convertible debt	`IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt`	$251.25K	USD	Annual
Original issue discount on convertible debt	`IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt`	$12.60K	USD	Annual
Conversion of notes payable to convertible notes	`ConversionOfShareholderNoteToConvertibleDebt`	-	USD	Annual
Conversion of notes payable to convertible notes	`ConversionOfShareholderNoteToConvertibleDebt`	$315.00K	USD	Annual
Beneficial conversion value upon issuance of convertible debt recorded as debt discount and an increase in capital in excess of par value	`IncreaseDecreaseInBeneficialConversionFeature`	$1.06M	USD	Annual
Beneficial conversion value upon issuance of convertible debt recorded as debt discount and an increase in capital in excess of par value	`IncreaseDecreaseInBeneficialConversionFeature`	$116.60K	USD	Annual
Issuance of warrants as derivative liability instruments upon conversion of note payable	`SupplementalIssuanceOfWarrantLiability`	-	USD	Annual
Issuance of warrants as derivative liability instruments upon conversion of note payable	`SupplementalIssuanceOfWarrantLiability`	$152.10K	USD	Annual
Issuance of warrants as derivative liability instruments and reduction of capital	`IssuanceOfDerivativeLiabilityInstrumentsAndReductionOfAdditionalPaidInCapital`	$3.06M	USD	Annual
Issuance of warrants as derivative liability instruments and reduction of capital	`IssuanceOfDerivativeLiabilityInstrumentsAndReductionOfAdditionalPaidInCapital`	$1.38M	USD	Annual
Derivative warrant liability recorded as original issuance discount to debt	`DerivativeWarrantLiabilityRecordedAsOriginalIssuanceDiscountToDebt`	$92.75K	USD	Annual
Derivative warrant liability recorded as original issuance discount to debt	`DerivativeWarrantLiabilityRecordedAsOriginalIssuanceDiscountToDebt`	-	USD	Annual

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-6.13M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time
Distribution of 5,000,000 warrants for common stock, exercise price of $3.00 per share	`DecreaseToAdditionalPaidInCapitalWarrantIssued`	$-1.55M	USD	Annual
Stock based compensation under Equity Incentive Plan	`StockIssuedDuringPeriodValueShareBasedCompensation`	$722.21K	USD	Annual
Stock based compensation under Equity Incentive Plan	`StockIssuedDuringPeriodValueShareBasedCompensation`	$376.44K	USD	Annual
Options granted as payment for equity securities	`StockIssuedDuringPeriodValueIssuedForServices`	$10.00K	USD	Annual
Common stock issued as payment of services and accounts payable	`StockIssuedDuringPeriodOfStocksAndWarrantsForServicesOrClaim`	$517.75K	USD	Annual
Common stock issued upon exercise of Convertible Notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Common stock issued in private placement	`StockIssuedDuringPeriodValueNewIssues`	$2.34M	USD	Annual
Common stock issued in private placement	`StockIssuedDuringPeriodValueNewIssues`	$-4.53K	USD	Annual
Common stock issued in private placement, shares	`StockIssuedDuringPeriodSharesNewIssues`	3.24M	shares	Point-in-time
Common stock issued in private placement, shares	`StockIssuedDuringPeriodSharesNewIssues`	1.71M	shares	Point-in-time
Merger of 22nd Century Limited and 22nd Century Group	`StockIssuedDuringPeriodValueAcquisitions`	-	USD	Annual
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$1.06M	USD	Point-in-time
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$116.60K	USD	Annual
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$1.06M	USD	Annual
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$116.60K	USD	Point-in-time
Common stock issued in private placement	`StockIssuedDuringPeriodValueNewIssuesTwo`	$455.64K	USD	Annual
Net income (loss)	`ProfitLoss`	$-1.35M	USD	Annual
Net income (loss)	`ProfitLoss`	$-6.74M	USD	Annual
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-6.13M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.09M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.